We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Economic constraints often cause developing countries to hold back on developing novel technologies. But many argue that taking advantage of the current window of opportunity to develop genomic medicine will contribute to economic growth and social welfare.

In this article, Gerardo Jimenez-Sanchez of Johns Hopkins University Mexico outlines plans to develop a genomic programme in Mexico that focuses on national health problems. The plans, which include establishing an Institute of Genomic Medicine, are being developed by a consortium of leading Mexican scientific and health institutes.

The consortium has already established three new graduate courses in genomic medicine at the National Autonomous University of Mexico, and aims to get the Mexican Institute of Genomic Medicine off the ground by the end of this year.

Link to article in Science

Reference: Science 300, 295 (2003)